# Synchronous occurrence of Waldenström macroglobulinemia and HER2-positive gastric adenocarcinoma with gastrointestinal stromal tumor: a rare case report

**Authors:** Yingming Jin, Zhilong Shi, Kesang Li, Tianjiao Liu, Zhi Fang

PMC · DOI: 10.3389/fonc.2025.1554206 · Frontiers in Oncology · 2025-05-16

## TL;DR

This case report describes a rare instance where a patient had three different cancers—Waldenström macroglobulinemia, HER2-positive gastric cancer, and a gastrointestinal stromal tumor—all occurring at the same time.

## Contribution

This is the first reported case of Waldenström macroglobulinemia occurring alongside HER2-positive gastric adenocarcinoma and a gastrointestinal stromal tumor.

## Key findings

- An 80-year-old male was diagnosed with Waldenström macroglobulinemia, HER2-positive gastric adenocarcinoma, and a low-risk gastrointestinal stromal tumor.
- The patient's bone marrow analysis confirmed Waldenström macroglobulinemia with the MYD88 L265P mutation and elevated IgM levels.
- This triple malignancy represents a rare and previously unreported combination of three distinct cancers.

## Abstract

There are very few reports of gastric cancer (GC) and gastrointestinal stromal tumor (GIST) occurring at the same time in the literature. In particular, the collision of GIST and human epidermal growth factor receptor-2 (HER-2)-positive gastric carcinoma in a patient with Waldenström macroglobulinemia (WM) has never been reported. We report the case of an 80-year-old male who initially presented with dizziness with fatigue for more than 1 month. He underwent total gastrectomy. Pathology revealed GC (moderately to poorly differentiated tubular adenocarcinoma), GIST (low-risk category) and low-grade small B-cell lymphoma with plasmacytoid differentiation. Furthermore, the diagnosis of WM was made after cytomorphologic and immunohistochemical analysis of the patient’s bone marrow revealed the presence of lymphoplasma cells along with the MYD88 L265P
 mutation and an increased level of serum monoclonal immunoglobulin M (IgM). To our knowledge, this is the first case of such an association where WM occurred with concomitant HER2-positive gastric adenocarcinoma and gastric GIST. A review of the literature concerning the incredibly uncommon simultaneous triple incidence of malignant tumors with distinct histogenesis is presented below.

## Linked entities

- **Genes:** MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615]
- **Proteins:** ERBB2 (erb-b2 receptor tyrosine kinase 2)
- **Diseases:** Waldenström macroglobulinemia (MONDO:0100280), gastric cancer (MONDO:0001056), gastrointestinal stromal tumor (MONDO:0011719)

## Full-text entities

- **Genes:** MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** GC (MESH:D013274), fatigue (MESH:D005221), malignant tumors (MESH:D009369), tubular adenocarcinoma (MESH:D000230), WM (MESH:D008258), dizziness (MESH:D004244), GIST (MESH:D046152), small B-cell lymphoma (MESH:D016393)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** L265P

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12122335/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12122335/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12122335/full.md

---
Source: https://tomesphere.com/paper/PMC12122335